Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Fluarix

Fluarix

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Fluarix

32 trials tracked of Fluarix: 14 in phase 3 or 4 and 1 with published results. The most-cited published study has 45 citations.

32Trials tracked
14Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 4 Phase 3 10 Phase 2 14 Phase 1 2 Other / NA 2
  1. Phase 4 Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP Completed · 45 cited
  2. Phase 4 Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™ Completed
  3. Phase 4 Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™ Completed
  4. Phase 4 Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old Completed
  5. Phase 3 Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above Completed
  6. Phase 3 Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) Completed
Show 26 more trials
  1. Phase 3 Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults Completed
  2. Phase 3 A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults Completed
  3. Phase 3 Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults Completed
  4. Phase 3 Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children Completed
  5. Phase 3 Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children Completed
  6. Phase 3 Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults Completed
  7. Phase 3 Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age Completed
  8. Phase 3 Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older Completed
  9. Phase 2 Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children Completed
  10. Phase 2 Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population Completed
  11. Phase 2 Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children Completed
  12. Phase 2 Study to Evaluate an Influenza Vaccine Candidate Completed
  13. Phase 2 Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly Completed
  14. Phase 2 Influenza Vaccine in Pregnant Women Completed
  15. Phase 2 A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health Completed
  16. Phase 2 Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age Completed
  17. Phase 2 Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate Completed
  18. Phase 2 Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults Completed
  19. Phase 2 Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate Completed
  20. Phase 2 Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults Completed
  21. Phase 2 Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A Completed
  22. Phase 2 Revaccination With Influenza Vaccine GSK1247446A Completed
  23. Phase 1 Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix Completed
  24. Phase 1 Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children Completed
  25. N/A Perturbing of HIV Reservoir With Immune Stimulation Completed
  26. N/A Immune Responses Induced by Different Licensed Influenza Vaccines Completed

Showing the 32 most-cited and recently-updated of 32 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.